Pleural	JJ
mesothelial	JJ
cell	NN
differentiation	NN
and	CC
invasion	NN
in	IN
fibrogenic	JJ
lung	NN
injury	NN
.	.

The	DT
origin	NN
of	IN
the	DT
myofibroblast	NN
in	IN
fibrotic	JJ
lung	NN
disease	NN
is	VBZ
uncertain	JJ
,	,
and	CC
no	DT
effective	JJ
medical	JJ
therapy	NN
for	IN
fibrosis	NN
exists	VBZ
.	.

We	PRP
have	VBP
previously	RB
demonstrated	VBN
that	IN
transforming-growth-factor-b1	NN
(	(
TGF-b1	NN
)	)
induces	VBZ
pleural	JJ
mesothelial	JJ
cell	NN
(	(
PMC	NN
)	)
transformation	NN
into	IN
myofibroblasts	NNS
and	CC
haptotactic	JJ
migration	NN
in	FW
vitro	FW
.	.

Whether	IN
PMC	NN
differentiation	NN
and	CC
migration	NN
occurs	VBZ
in	FW
vivo	FW
,	,
and	CC
whether	IN
this	DT
response	NN
can	MD
be	VB
modulated	VBN
for	IN
therapeutic	JJ
benefit	NN
,	,
is	VBZ
unknown	JJ
.	.

Here	RB
,	,
using	VBG
mice	NNS
recombinant	JJ
for	IN
green	JJ
fluorescent	JJ
protein	NN
(	(
GFP	NN
)	)
driven	VBN
by	IN
the	DT
Wilms	NN
tumor-1	NN
(	(
WT-1	NN
)	)
promoter	NN
,	,
we	PRP
demonstrate	VBP
PMC	NN
trafficking	NN
into	IN
the	DT
lung	NN
and	CC
differentiation	NN
into	IN
myofibroblasts	NNS
.	.

Carbon	NNP
monoxide	NNP
or	CC
the	DT
induction	NN
of	IN
heme-oxygenase-1	NN
(	(
HO-1	NN
)	)
inhibited	VBD
the	DT
expression	NN
of	IN
myofibroblast	NN
markers	NNS
,	,
contractility	NN
,	,
and	CC
haptotaxis	NN
in	IN
PMCs	NNS
treated	VBN
with	IN
TGF-b1	NN
.	.

Intrapleural	JJ
HO-1	NN
induction	NN
inhibited	VBD
PMC	NN
migration	NN
after	IN
intratracheal	JJ
fibrogenic	JJ
injury	NN
.	.

PMCs	NNS
from	IN
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
exhibited	VBD
increased	VBN
expression	NN
of	IN
myofibroblast	NN
markers	NNS
and	CC
enhanced	VBD
contractility	NN
and	CC
haptotaxis	NN
,	,
compared	VBN
with	IN
normal	JJ
PMCs	NNS
.	.

Carbon	NNP
monoxide	NN
reversed	VBD
this	DT
IPF	NN
PMC	NN
profibrotic	JJ
phenotype	NN
.	.

WT-1-expressing	JJ
cells	NNS
were	VBD
present	JJ
within	IN
fibrotic	JJ
regions	NNS
of	IN
the	DT
lungs	NNS
in	IN
IPF	NN
subjects	NNS
,	,
supporting	VBG
a	DT
role	NN
for	IN
PMC	NN
differentiation	NN
and	CC
trafficking	NN
as	IN
contributors	NNS
to	TO
the	DT
myofibroblast	JJ
population	NN
in	IN
lung	NN
fibrosis	NN
.	.

Our	PRP$
findings	NNS
also	RB
support	VBP
a	DT
potential	JJ
role	NN
for	IN
pleural-based	JJ
therapies	NNS
to	TO
modulate	VB
pleural	JJ
mesothelial	JJ
activation	NN
and	CC
parenchymal	JJ
fibrosis	NN
progression	NN
.	.

